Efficacy and Safety of Intramuscular Midazolam Compared to Buccal Midazolam in Pediatric Seizures

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Seizures
Interventions
DRUG

Buccal midazolam

Study subject will receive Buccal midazolam, Intramuscular placebo.

DRUG

Intramuscular midazolam

Study subject will receive Intramuscular midazolam,Buccal placebo

Trial Locations (1)

3050

Hamad medical corporation, Doha

Sponsors
All Listed Sponsors
lead

Hamad Medical Corporation

INDUSTRY

NCT02897856 - Efficacy and Safety of Intramuscular Midazolam Compared to Buccal Midazolam in Pediatric Seizures | Biotech Hunter | Biotech Hunter